Monteiro, Lis Marie; Löbenberg, Raimar; Cotrim, Paulo Cesar; Araujo, Gabriel Lima Barros de 
; Bou-Chacra, Nadia Araci
Source: Biomed Research International. Unidades: FM, FCF
Subjects: LEIHMANIA, NANOPARTÍCULAS, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Lis Marie et al. Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases. Biomed Research International, v. 2017, p. 11 , 2017Tradução . . Disponível em: https://doi.org/10.1155/2017/9781603. Acesso em: 14 nov. 2024.APA
Monteiro, L. M., Löbenberg, R., Cotrim, P. C., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2017). Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases. Biomed Research International, 2017, 11 . doi:10.1155/2017/9781603NLM
Monteiro LM, Löbenberg R, Cotrim PC, Araujo GLB de, Bou-Chacra NA. Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases [Internet]. Biomed Research International. 2017 ; 2017 11 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1155/2017/9781603Vancouver
Monteiro LM, Löbenberg R, Cotrim PC, Araujo GLB de, Bou-Chacra NA. Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases [Internet]. Biomed Research International. 2017 ; 2017 11 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1155/2017/9781603
